A comparison of culture-positive and culture-negative health-care- associated pneumonia

Chest

Volumn 137, Issue 5, 2010, Pages 1130-1137

  Labelle, Andrew J ^a   Arnold, Heather ^b   Reichley, Richard M ^c   Micek, Scott T ^b   Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c BJC HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAPENEM; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN; HYPERTENSIVE AGENT; LINEZOLID; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONCURRENT INFECTION; DISEASE SEVERITY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MOUTH FLORA; NURSING HOME; OUTCOME ASSESSMENT; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; TREATMENT DURATION; URBAN AREA;

EID: 77951844649     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1652     Document Type: Article

References (26)

1. Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes-Proceedings of the HCAP Summit. Clin Infect Dis. 2008;46(suppl 4):S296-S334.
2. Kollef MH, Napolitano LM, Solomkin JS, et al. Health care-associated infection (HCAI): a critical appraisal of the emerging threat. Proceedings of the HCAI Summit. 2008;47(suppl 2):S55-S99.
3. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862. (Pubitemid 43062645)
4. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother. 2007;51(10):3568-3573. (Pubitemid 47519345)
5. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med. 2008;168(20):2205-2210.
6. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med. 2002;162(16):1849-1858.
7. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167(13):1393- 1399. (Pubitemid 47052438)
8. Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med. 2009;150(1):19-26.
9. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest. 2009;135(3):633-640.
10. Craven DE. What is healthcare-associated pneumonia, and how should it be treated? Curr Opin Infect Dis. 2006;19(2):153-160.
11. Rowe BH, Campbell SG, Boudreaux ED, et al. Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin. Acad Emerg Med. 2007;14(7):607-615.
12. Rello J, Bodi M, Mariscal D, et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest. 2003;123(1):174-180. (Pubitemid 36126730)
13. Yusuf SW, Ali SS, Swafford J, et al. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006;85(2):86-94.
14. Zamorano J, Sanz J, Moreno R, et al. Comparison of outcome in patients with culture-negative versus culture-positive active infective endocarditis. Am J Cardiol. 2001; 87(12):1423-1425. (Pubitemid 32523036)
15. Fariñas-Alvarez C, Fariñas MC, Fernández-Mazarrasa C, Llorca J, Delgado-Rodríguez M. Epidemiological differences between sepsis syndrome with bacteremia and culture-negative sepsis. Infect Control Hosp Epidemiol. 2000;21(10):639-644.
16. Garau J, Baquero F, Pérez-Trallero E, et al; NACER Group. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect. 2008;14(4):322-329.
17. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
18. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006;129(5):1210-1218.
19. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
20. Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004;32(11):2183-2190.
21. Leone M, Garcin F, Bouvenot J, et al. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med. 2007;35(2):379-385., 386.
22. Ewig S, Torres A, Angeles Marcos M, et al. Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J. 2002;20(5):1254-1262. (Pubitemid 35331886)
23. Chan YR, Morris A. Molecular diagnostic methods in pneumonia. Curr Opin Infect Dis. 2007;20(2):157-164.
24. Schneeberger PM, Dorigo-Zetsma JW, van der Zee A, van Bon M, van Opstal JL. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection. Scand J Infect Dis. 2004;36(4):269-273. (Pubitemid 38714179)
25. Carratalà J, Garcia-Vidal C. What is healthcare-associated pneumonia and how is it managed? Curr Opin Infect Dis. 2008;21(2):168-173.
26. Tillotson GS, Ball P. Meeting report: Fourth Forum on Respiratory Tract Infections, Sitges, Spain, 8-11 February 2007. J Antimicrob Chemother. 2007;60(3):464-469. (Pubitemid 47299858)